Phase II Study of Metronomic Treatment With Daily Oral Vinorelbine as First-line Chemotherapy in Patients With Advanced/Metastatic HR+/HER2- Breast Cancer Resistant to Endocrine Therapy
Phase of Trial: Phase II
Latest Information Update: 10 Mar 2018
At a glance
- Drugs Vinorelbine (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms VinoMetro
- 18 Jan 2018 Status has been changed to discontinue.
- 08 Sep 2017 Trial design presented at 42nd European Society for Medical Oncology Congress.
- 08 Sep 2017 According to trial design presented at 42nd European Society for Medical Oncology Congress, 5 patients were enrolled till 30 Apr 2017 and it is planned to include 45 (39 evaluable) patients at 8 German sites until September 2018.